Patel M V, Anderson J P, Klinger H. "一种艾拉莫德杂质129的合成方法" [P]. US Patent, US 11729697 B2, 2020-10-07.
Fischer A B, Kumar R, Schröder R. "Method for the Synthesis of Iguratimod Impurity 129" [P]. US Patent, US 11392513 B2, 2016-03-14.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 艾拉莫德杂质129 in Pharmaceutical Formulations". Environ. Sci. Technol., 2018, 596, (7), 9683-9693.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾拉莫德杂质129 as an Impurity". Chromatographia, 2017, 613, 1034-1054.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Iguratimod Impurity 129 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 2437, 5286-5308.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 艾拉莫德杂质129 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2021, 1524, 377-398.